← Back to Bills
HR 9275118th CongressFailed / ExpiredHouse

End Kidney Deaths Act

Policy Area: Taxation
View on Congress.gov
Origin Chamber
House
Last Updated
Dec 19, 2024
Latest Action Date
Dec 17, 2024

Latest Action

Referred to the Subcommittee on Health.

Official Summary

Official summary has not been imported yet.

GovScope Watchdog™

AI Government Intelligence™
Executive Summary

The End Kidney Deaths Act (H.R. 9275) is a bill introduced in the 118th Congress aimed at addressing issues related to kidney disease mortality. The bill was referred to the Subcommittee on Health but did not advance further and is currently classified as failed or expired. The bill is categorized under the policy area of Taxation, although no official summary or full text is available to provide detailed provisions or mechanisms. The latest recorded action was its referral to the Subcommittee on Health on December 17, 2024.

Bottom Line

H.R. 9275, the End Kidney Deaths Act, was introduced but did not progress beyond subcommittee referral and is now expired, with limited publicly available information on its content or specific measures.

Policy Risk Level
🟡 Medium
Neutral Risk Assessment
Key Points
  • The bill was introduced in the House during the 118th Congress and referred to the Subcommittee on Health.
  • It is classified under the policy area of Taxation, though no detailed summary or text is available.
  • The bill status is failed or expired, indicating it did not advance through the legislative process.
Who Benefits?

["Potential beneficiaries could include individuals affected by kidney disease, healthcare providers, and related health agencies, assuming the bill's intent is to reduce kidney disease mortality.", 'Tax authorities or sectors involved in taxation policy might be indirectly involved given the policy area classification.']

Potential Concerns

['Lack of available full text and official summary limits understanding of the bill’s provisions and potential costs.', 'Without detailed provisions, it is unclear what authority or oversight mechanisms would have been established.', 'The classification under Taxation may imply fiscal implications that are not detailed, posing challenges for assessing budgetary impact.']

Political Context

The bill was introduced in the House and referred to the Subcommittee on Health but did not advance further, reflecting limited legislative movement. The absence of detailed summary or text suggests it may not have received significant attention or debate. Its classification under Taxation is notable but unexplained in available data.

Hidden Impact Review

Hidden impact flags detected: 2

GovScope reviewed 2 policy-risk categories. Hover for a quick definition. Click detected flags for bill-specific details.

2 Detected
Detected Flags
Indirect Effects

['If enacted, the bill could have influenced healthcare policy related to kidney disease, potentially affecting healthcare providers and patients.', 'Tax-related provisions might have had broader implications for fiscal policy or government revenue, though specifics are unavailable.']

GovScope Watchdog Notes

The lack of publicly available summary and full text for H.R. 9275 limits transparency and oversight opportunities. Stakeholders and the public cannot fully evaluate the bill’s intent, provisions, or potential impacts. The classification under Taxation without further detail raises questions about fiscal implications that remain unaddressed. Monitoring such gaps is important for ensuring informed legislative processes.

Passage Likelihood: LowConfidence: 60%Model: gpt-4.1-mini

GovScope Intelligence Roadmap

Future bill intelligence will connect sponsors, committee referrals, related votes, campaign finance, disclosures, and stock trades into one legislative intelligence view.

Enterprise Ready